Sign in

Joe Sabatino

@jsabatino37.bsky.social
2.7K followers 757 following 342 posts

MS Neurologist, T cell immunologist, UCSF Dept of Neurology, Weill Institute for Neurosciences. All posts are my own and not on behalf of UCSF

PostsRepliesMedia
Joe Sabatino @jsabatino37.bsky.social · 18h
The trogocytosis plot of T cell-B cell interactions thickens! T–B interactions yield CD3+ B cells and CD20+ T cells with pathogenic features in multiple sclerosis www.pnas.org/doi/10.1073/...
pnas.org
T–B interactions yield CD3+ B cells and CD20+ T cells with pathogenic features in multiple sclerosis | PNAS
Classically, B and T cells are differentiated by their mutually exclusive expression of surface markers such as CD3 and CD20, but it is now establi...
1110
Reposted by Joe Sabatino
brandon-beaber.bsky.social @brandon-beaber.bsky.social · 02/10/2026
The FDA is reviewing an application for the investigational multiple sclerosis drug fenebrutinib which would be the first available bruton's tyrosine kinase inhibitor. They should make a decision within 6 months. multiplesclerosisnewstoday.com/news-posts/2...
multiplesclerosisnewstoday.com
FDA grants priority review to 'high-efficacy' oral drug for 2 MS types
The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved for two MS types.
031
Reposted by Joe Sabatino
Kilian Schober @kischober.bsky.social · 02/10/2026
New preprint from our lab, now on bioRxiv! We are VERY excited about this one! www.biorxiv.org/content/10.6... How does Epstein–Barr virus (EBV) immunity become linked to multiple sclerosis (MS)? (1/8)
biorxiv.org
A pro-inflammatory effector-memory T cell program links peripheral EBV priming to CNS autoimmunity
T and B cell-mediated immunosurveillance of the central nervous system (CNS) can become maladaptive in multiple sclerosis (MS). Epstein-Barr virus (EBV) is a likely driver of MS, yet how exactly EBV-s...
1169
Reposted by Joe Sabatino
bioRxiv Immunology @biorxiv-immuno.bsky.social · 01/10/2026
A pro-inflammatory effector-memory T cell program links peripheral EBV priming to CNS autoimmunity www.biorxiv.org/content/10.64898/20…
042
Joe Sabatino @jsabatino37.bsky.social · 01/10/2026
Autoantibody landscapes in Long COVID with neurological symptoms show heterogeneity without a shared disease signature Congrats to Debanjana Chakravarty, Michael Wilson, Sam Pleasure and colleagues! insight.jci.org/articles/vie...
insight.jci.org
JCI Insight - Autoantibody landscapes in Long COVID with neurological symptoms show heterogeneity without a shared disease signature
000
Joe Sabatino @jsabatino37.bsky.social · 01/10/2026
The influence of anti-CD20-directed B cell depletion across different agents on Epstein-Barr virus-specific humoral and cellular immunity in patients with multiple sclerosis link.springer.com/article/10.1...
link.springer.com
The influence of anti-CD20-directed B cell depletion across different agents on Epstein-Barr virus-specific humoral and cellular immunity in patients with multiple sclerosis - Journal of Neuroinflamma...
Background Epidemiological evidence has established a central role of Epstein-Barr virus (EBV) in the pathogenesis of multiple sclerosis (MS). While EBV-specific T-cell responses may influence disease...
030
Joe Sabatino @jsabatino37.bsky.social · 01/10/2026
Reminder! If you are interested applying to our MS and Neuroimmunology fellowship, please attend our virtual Open House on Friday, October 2 at 10-11 am PT. We offer clinical and clinician-scientist training tracks Registration here: ucsf.zoom.us/webinar/regi...
011
Reposted by Joe Sabatino
bioRxiv Immunology @biorxiv-immuno.bsky.social · 29/09/2026
MHC restriction is structurally encoded by the T cell receptor germline www.biorxiv.org/content/10.64898/20…
021
Reposted by Joe Sabatino
Michael Paley, M.D., Ph.D. @drmapaley.bsky.social · 29/09/2026
You can now view our abstract using this link and the summary images below: www.biorxiv.org/content/10.6... @obigriffith.bsky.social @malachigriffith.bsky.social @thehumanborch.bsky.social #Rheumsky #axSpA (1/4)
142
Reposted by Joe Sabatino
Schumacher Lab @schumacher-lab.bsky.social · 29/09/2026
Hi, we would like to introduce PAIR-Scan, an HLA-agnostic library-on-library screening technology that can identify reactive TCR–antigen pairs with optimal killing activity among up to ~100,000 possible candidate pairs in a single-step. 🧵(1/7) www.biorxiv.org/content/10.6...
biorxiv.org
163
Reposted by Joe Sabatino
Michael D Kornberg @mdkornberg.bsky.social · 29/09/2026
Succinct and clear-headed perspective on the unknowns of MS and what they might mean for its pathogenesis. I enjoyed reading it. www.nature.com/articles/s41...
nature.com
What the ‘negative space’ tells us about the immunology of multiple sclerosis - Nature Reviews Immunology
By exploring five enduring “negative spaces” in multiple sclerosis (MS) research, Kaufmann, Gold and Fugger challenge simple explanations of disease pathogenesis. Their Comment argues that MS emerges ...
131
Reposted by Joe Sabatino
bioRxiv Immunology @biorxiv-immuno.bsky.social · 28/09/2026
Common viral infections seed regionally distinct resident memory T cells in the human CNS www.biorxiv.org/content/10.64898/20…
063
Joe Sabatino @jsabatino37.bsky.social · 25/09/2026
Spatial organization of AQP4 water channel expression in the human brain www.science.org/doi/10.1126/...
science.org
Spatial organization of AQP4 water channel expression in the human brain
Aquaporin-4 (AQP4) water channels support the glymphatic system, a brain-wide pathway that clears cerebral waste products. Here, we use AQP4 gene expression to reconstruct a whole-brain glymphatic-rel...
042
Joe Sabatino @jsabatino37.bsky.social · 25/09/2026
Pleased to be joining Joanne Guo as the new Assistant Fellowship Program Directory for our MS and Neuroimmunology Fellowship at UCSF We are having a virtual Open House on October 2 at 10-11 am PT for those interesting in learning more! Registration here: ucsf.zoom.us/webinar/regi...
030
Joe Sabatino @jsabatino37.bsky.social · 25/09/2026
VDJdb in 2026: boosting T-cell receptor recognition evidence using paratope embeddings and AI-based structure prediction academic.oup.com/nar/advance-...
academic.oup.com
VDJdb in 2026: boosting T-cell receptor recognition evidence using paratope embeddings and AI-based structure prediction
Abstract. We present a significant update to VDJdb, introducing substantial enhancements to both the data content and the technical infrastructure. The int
060
Joe Sabatino @jsabatino37.bsky.social · 24/09/2026
Immune signatures of common exposures through co-occurrence of T-cell receptors in tens of thousands of donors www.frontiersin.org/journals/imm...
frontiersin.org
Frontiers | Immune signatures of common exposures through co-occurrence of T-cell receptors in tens of thousands of donors
BackgroundMemory T cells are records of clonal expansion from prior immune exposures such as infections, vaccines and chronic diseases. Some of the receptors...
101
Reposted by Joe Sabatino
Marson Lab @marsonlab.bsky.social · 22/09/2026
Join us! 👇
063
Reposted by Joe Sabatino
Stacey L. Clardy @staceylclardy.bsky.social · 22/09/2026
Train in autoimmune neurology: adult + pediatric clinical care, research, education and real-world experience. Applications are open now; first interviews begin late fall 2026. neuro.fellowship@hsc.utah.edu medicine.utah.edu/neurology/fellows…
Utah Autoimmune Neurology Fellowship
022
Reposted by Joe Sabatino
Hashem Koohy @hkoohy.bsky.social · 21/09/2026
Very honoured to be hosting Prof @kischober.bsky.social at Unravelling T cell recogition webinar series @imm.ox.ac.uk Kilian will present his latest work exploring how EBV-reactive T cells may contribute to CNS autoimmunity in multiple sclerosis. Join me. #TCells #Immunology #MultipleSclerosis #EBV
094
Joe Sabatino @jsabatino37.bsky.social · 19/09/2026
Anti-CD40L prevents meningeal B cell aggregates and mitigates progressive autoimmune encephalomyelitis academic.oup.com/brain/advanc...
academic.oup.com
Validate User
021
Joe Sabatino @jsabatino37.bsky.social · 19/09/2026
This is a great overview and critique by Gavin Giovannoni of the recent EBV MS relapse paper
042
Reposted by Joe Sabatino
Stacey L. Clardy @staceylclardy.bsky.social · 18/09/2026
Applications are open for Utah's Autoimmune Neurology Fellowship—adult + pediatric training, clinical care, research and diagnostics. First interviews begin late fall 2026. neuro.fellowship@hsc.utah.edu medicine.utah.edu/neurology/fellows…
Utah Autoimmune Neurology Fellowship applications are open
022
Joe Sabatino @jsabatino37.bsky.social · 18/09/2026
EBNA1381-452 and Cross-Reactive Antibody Responses Reveal Immune Signatures in Multiple Sclerosis www.neurology.org/doi/10.1212/...
neurology.org
EBNA1381-452 and Cross-Reactive Antibody Responses Reveal Immune Signatures in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
Background and ObjectivesInfection with the Epstein-Barr virus is a prerequisite for the development of multiple sclerosis (MS). Recent evidence has identified an antibody response against a peptide r...
020
Joe Sabatino @jsabatino37.bsky.social · 18/09/2026
Universal seropositivity, markers of recurrent reactivation, and a convergent T-cell response implicate cytomegalovirus in Susac syndrome www.researchsquare.com/article/rs-1...
researchsquare.com
Universal seropositivity, markers of recurrent reactivation, and a convergent T-cell response implicate cytomegalovirus in Susac syndrome
Susac syndrome (SuS) is a rare brain, retina, and inner ear endotheliopathy, in which CD8⁺ T cells are thought to target the microvascular endothelium. We applied unbiased, HLA-restricted antigen-spec...
020
Reposted by Joe Sabatino
Kilian Schober @kischober.bsky.social · 17/09/2026
Check out this webinar hosted by @hkoohy.bsky.social (@ox.ac.uk). I am looking forward to speaking about our new findings on the role of EBV-specific T cells in multiple sclerosis (preprint coming soon). More info in the flyer - the link for registration is here, too: us06web.zoom.us/meeting/regi...
042
Reposted by Joe Sabatino
Mohamed ElTanbouly @plasmacellguy.bsky.social · 16/09/2026
Hello! I've started my lab and we're looking to hire at multiple positions: 1-Postdoc 2-Scientist (primarily Computational biologists) 2-Lab manager 3-Tech If you're interested, please reach out to my institutional email. Looking forward to discussing further.
084
Joe Sabatino @jsabatino37.bsky.social · 16/09/2026
EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse www.nature.com/articles/s41...
nature.com
EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse - Nature Medicine
Increased expression of EBV reactivation genes in B cells and MS risk genes targeted by the EBV protein EBNA-2 precedes MS attacks, linking EBV reactivation and genetic risk to the development of MS r...
1104
Reposted by Joe Sabatino
Arc Institute @arcinstitute.org · 15/09/2026
Want to join Arc? We're hiring experts in disease bio, computational bio, functional genomics, and NGS for our Tech Centers, plus postdocs and research associates in our Core Labs. All roles are based in Palo Alto, and are on-site or hybrid. Learn more or apply here: lnkd.in/gyfgqR3n
arcinstitute.org
Jobs | Arc Institute
Arc Institute is an independent nonprofit research organization headquartered in Palo Alto, California.
045
Reposted by Joe Sabatino
bioRxiv Immunology @biorxiv-immuno.bsky.social · 14/09/2026
PAIR-Scan: Single-step identification of highly potent TCR-neoantigen pairs through library-on-library screening www.biorxiv.org/content/10.64898/20…
042
Joe Sabatino @jsabatino37.bsky.social · 14/09/2026
Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis Exciting new work from Sasha Gupta, Bruce Cree and colleagues! www.medrxiv.org/content/10.6...
medrxiv.org
Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis
Treatment targeting progressive multiple sclerosis (MS) have limited efficacy, as central nervous system (CNS) resident B cells are resistant to peripheral B cell depletion by antiCD20 monoclonal anti...
030
Reposted by Joe Sabatino
Waggoner Lab @labwaggoner.bsky.social · 11/09/2026
Opinion @cp-trendsimmuno.bsky.social Understanding HLA risk in immune-mediated inflammatory diseases requires antigen discovery www.cell.com/trends/immun...
061
Joe Sabatino @jsabatino37.bsky.social · 11/09/2026
Multimodal discovery of a pathogenic B cell-dependent T cell state in multiple sclerosis academic.oup.com/brain/advanc...
academic.oup.com
Multimodal discovery of a pathogenic B cell-dependent T cell state in multiple sclerosis
Farooq et al. show that B cell depletion in multiple sclerosis indirectly disrupts a proinflammatory-cytotoxic T cell state. Convergent evidence across dis
092
Reposted by Joe Sabatino
The Sumaira Foundation (TSF) @thesumairafdn.bsky.social · 10/09/2026
💙 #MOGAD update: The FDA granted Priority Review to Genentech’s application for Enspryng® (satralizumab). In Phase III, it reduced relapse risk by 68%. If approved, it could be the first FDA-approved MOGAD treatment. Decision expected Jan. 10, 2027. www.gene.com/media/press-...
gene.com
Genentech: Press Releases | U.S. FDA GRANTS PRIORITY REVIEW FOR GENENTECH’S ENSPRYNG FOR MOGAD, AN AUTOIMMUNE DISEASE WITH NO APPROVED TREATMENTS
The filing acceptance is based on positive results from the Phase III METEOROID study, which showed that Enspryng provided consistent, clinically meaningful improvements for people living with MOGAD.
011
Reposted by Joe Sabatino
Eric Topol @erictopol.bsky.social · 09/09/2026
Marked benefit of Covid updated or booster vaccination in people with autoimmune conditions Real world evidence for over 60,000 individuals with major (40-70%) reduction of hospitalization acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
acrjournals.onlinelibrary.wiley.com
Updated <fc>COVID</fc>‐19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions
Objective We aimed to assess the association between COVID-19 vaccination status and COVID-19-related hospital admissions, need for mechanical ventilation or extracorporeal membrane oxygenation (ECM...
321988
Reposted by Joe Sabatino
brandon-beaber.bsky.social @brandon-beaber.bsky.social · 09/09/2026
For people with multiple sclerosis with asymptomatic active lesions on MRI, dose high dose steroid treatment reduce conversion to a "black hole" on MRI, indicating irreversible axonal damage? According to this randomized trial, no! It makes no difference pubmed.ncbi.nlm.nih.gov/42711838/
pubmed.ncbi.nlm.nih.gov
Evaluation of MRI asymptomatic gadolinium-enhancing lesions conversion to persistent black hole with high‑dose methylprednisolone pulse therapy in relapsing remitting multiple sclerosis patients: a randomized trial - PubMed
Intravenous methylprednisolone pulse therapy administered for asymptomatic gadolinium-enhancing lesions was not associated with a statistically significant reduction in the formation of chronic T1 black holes over a 6-month follow-up period.
041
Reposted by Joe Sabatino
Jenna Norton @jenna-m-norton.bsky.social · 09/09/2026
NIH to continue discussing only the top 1/3 of applications. This is a disservice to the research community. Fewer applications will get the higher quality of review from discussion. Applicants will get less nuanced feedback from review. grants.nih.gov/grants/guide...
grants.nih.gov
NOT-OD-26-114: Continuation of Modifications to Peer Review Practices
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Continuation of Modifications to Peer Review Practices NOT-OD-26-114. NIH
26135
Reposted by Joe Sabatino
Proceedings of the National Academy of Sciences @pnas.org · 09/09/2026
Peptide-coupled red blood cells emerge as a promising autologous cell therapy for achieving antigen-specific immune tolerance in multiple sclerosis in a clinical trial of 10 patients. In PNAS: ow.ly/IkYP50ZKHUf
Clusters of proliferating and nonproliferating CD4+ T cells after 8 days of antigen stimulation.
041
Joe Sabatino @jsabatino37.bsky.social · 08/09/2026
Intestinal infections establish antigen-specific, long-lived memory CD4+ T cells in the brain and meninges www.nature.com/articles/s41...
nature.com
Intestinal infections establish antigen-specific, long-lived memory CD4+ T cells in the brain and meninges - Nature Neuroscience
Intestinal CD4+ T cells migrate to the dura and brain following gut infection with bacteria or parasites, establishing a long-lived memory population capable of proliferation and cytokine production f...
041
Joe Sabatino @jsabatino37.bsky.social · 08/09/2026
Epstein–Barr virus and multiple sclerosis: Mechanisms, therapeutic implications, and emerging interventions www.sciencedirect.com/science/arti...
sciencedirect.com
010
Reposted by Joe Sabatino
prot_papers @protpapers.bsky.social · 08/09/2026
Understanding HLA risk in immune-mediated inflammatory diseases requires antigen discovery pubmed.ncbi.nlm.nih.gov/42705941
012
Joe Sabatino @jsabatino37.bsky.social · 07/09/2026
Evolving role of CD8+ tissue-resident memory T cells in autoimmune and immune mediated inflammatory diseases: linking pathogenesis to therapeutic approaches www.frontiersin.org/journals/imm...
frontiersin.org
Frontiers | Evolving role of CD8+ tissue-resident memory T cells in autoimmune and immune mediated inflammatory diseases: linking pathogenesis to therapeutic approaches
Memory CD8+ T cells provide accelerated protection against intracellular pathogens and tumors. Circulating memory T cells recirculate through blood and lymph...
063
Reposted by Joe Sabatino
Max Kozlov @maxkozlov.bsky.social · 04/09/2026
🚨 The NIH is moving to transfer hundreds of millions of dollars in infectious-disease research projects to the DOD under a secret 10-year pact. Here’s what’s happening inside “Operation Prevailing Edge” 🧵👇 www.nature.com/articles/d41...
nature.com
Revealed: inside the US military's plan to tap huge sums from the NIH
An agreement paves the way for hundreds of millions of dollars’ worth of projects to be transferred from the NIH’s institute for infectious diseases to the Department of Defense.
26444377
Reposted by Joe Sabatino
UCSF Health @ucsfhealth.bsky.social · 05/09/2026
We’re proud to lead a $9 million effort to crack one of #myocarditis’ biggest mysteries: Why immune cells attack the heart. The long-term goal is "turning off the T cells attacking the heart while leaving the rest of the immune system intact," Dr. Josiah Gerdts explains. ucsfh.org/4qKxd3o
053
Reposted by Joe Sabatino
Max Kozlov @maxkozlov.bsky.social · 04/09/2026
Under pressure, the DOD just released the text of its secret 10-year agreement with the NIH. Here are the biggest revelations from the document 🧵
13590344
Reposted by Joe Sabatino
Paul Thomas @pgtimmune.bsky.social · 04/09/2026
TCR specificity prediction is advancing rapidly. The central question is not only which TCR sequence recognizes an antigen, but also which TCR pairings make recognition possible & where is the binding boundary? Our new paper tackles these questions. 🧵 www.science.org/doi/10.1126/...
science.org
Uneven TCR chain pairing constraints govern epitope recognition
Combinatorial pairing of independently recombined T cell receptor (TCR) α- and β-chains is central to diversifying the TCR repertoire. Although sequence motifs in one chain correlate with epitope reco...
22210
Reposted by Joe Sabatino
saligramalab.bsky.social @saligramalab.bsky.social · 03/09/2026
#For #TCR #Lovers look at this #great paper @pgtimmune.bsky.social Uneven TCR chain pairing constraints govern epitope recognition | Science www.science.org/doi/10.1126/...
science.org
Uneven TCR chain pairing constraints govern epitope recognition
Combinatorial pairing of independently recombined T cell receptor (TCR) α- and β-chains is central to diversifying the TCR repertoire. Although sequence motifs in one chain correlate with epitope reco...
184
Reposted by Joe Sabatino
Waggoner Lab @labwaggoner.bsky.social · 03/09/2026
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders @nejm.org www.nejm.org/doi/full/10....
032
Reposted by Joe Sabatino
Yang Luo @y-luo.bsky.social · 02/09/2026
📢 DPhil opportunity in our lab at @ox.ac.uk! We’re looking for a DPhil student to build a population-scale HLA–TCR atlas and investigate how genetic variation shapes human T-cell responses across health and disease. 🧬🦠 Apply before: *1 Dec 2026*. www.kennedy.ox.ac.uk/study-with-u...
kennedy.ox.ac.uk
Decoding HLA-restricted human T-cell immunity through a population-scale HLA–TCR atlas
053
Joe Sabatino @jsabatino37.bsky.social · 01/09/2026
Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells www.pnas.org/doi/abs/10.1...
pnas.org
Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells | PNAS
Inducing antigen-specific immune tolerance is a long-standing aim in organ-specific autoimmune diseases including multiple sclerosis (MS). We devel...
070
Reposted by Joe Sabatino
saligramalab.bsky.social @saligramalab.bsky.social · 31/08/2026
Our lab anticipate having #two #postdoctoral #positions starting beginning/late summer #2027. We are searching for candidates with #Tcell #expertise #protein #engineering and #ThymicTcellDevelopment.
055